Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Inovio Pharma (NQ: INO)
11.93 USD  +0.05 (+0.42%)
Official Closing Price  /  Updated: 7:59 PM EDT, Jun 5, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 18,795,200
Open 12.11
Bid (Size) 12.04 (4)
Ask (Size) 12.05 (14)
Prev. Close 11.88
Today's Range 11.26 - 12.32
52wk Range 1.915 - 19.36
Shares Outstanding 90,962,081
Dividend Yield N/A
Performance
YTD
+271.65%
+271.65%
1 Month
+13.94%
+13.94%
3 Month
-15.33%
-15.33%
6 Month
+400.21%
+400.21%
1 Year
+420.96%
+420.96%
Top News
More News
INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South Korea
- First COVID-19 vaccine clinical study approved in South Korea funded by CEPI through INOVIO, and supported by KCDC/KNIH Read More
from PR Newswire
Developing a COVID-19 Vaccine Quickly Proving to be a Daunting Task But Progress Still Expected
Financialnewsmedia.com News Commentary Read More
from PR Newswire
More News
Read More
Developing a COVID-19 Vaccine Quickly Proving to be a Daunting Task But Progress Still Expected
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Interesting INO Put And Call Options For July 24th
category Stocks
from Market News Video
UPDATE 2-Inovio plans human trials for potential COVID-19 vaccine in South Korea in June
category companyNews
from Reuters: Company News
UPDATE 1-Inovio plans human trials for potential COVID-19 vaccine in South Korea in June
category companyNews
from Reuters: Company News
3 Top Coronavirus Stocks to Buy in June
category MRNA , BNTX , MYL , and 5 more.
from Motley Fool
Inovio to Start a Phase 1/2 Study of its COVID-19 Vaccine in South Korea
category INO , MRNA , Market News
from Motley Fool
Inovio partners with non-profit organization to begin COVID-19 vaccine trial
category companyNews
from Reuters: Company News
Revisiting The Coronavirus Vaccine Race: Updates On The 10 Candidates In Clinics
category SNY , Market News , Health Care , and 20 more.
from Benzinga
Could the Rush to a Vaccine Hurt Coronavirus Stocks?
category MRNA , INO , NVAX , and 2 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.